Rebranding Normalized Pandemic‑Risk Research

Shifting the framing of 'gain‑of‑function' into risk‑management categories like P3CO has the practical effect of making formerly controversial high‑risk experiments routine within funded science. That rebranding lowers the political and institutional barriers to conducting experiments that intentionally create or modify pathogens with pandemic potential. — If normalization continues, it reshapes regulatory thresholds, expands where and how dangerous biology is practiced, and raises the stakes for independent biosafety oversight and public accountability.